McCarthy DM: Using H2-antagonist drugs. Drug Ther18:21-33, 1988
2.
Press release: The Health Strategy Group. New York, NY , 1985
3.
Jensen DM: Economic and health aspects of peptic ulcer disease and H2-receptors antagonists . Am J Med81:42-48, 1986 (suppl B)
4.
Peterson WL, Sturdevant RL, Frankel HD, et al: Healing of duodenal ulcer with an antacid regimen. N Engl J Med297:341-345, 1977
5.
Lam I.: Treatment of duodenal ulcer with antacid and sulpride. Gastroenterology76:315-320, 1979
6.
Bianchi PG, Parente F., Lazzaroni M., et al: Medium dose-antacids versus cimetidine in short term treatment of doudenal ulcer. J Clin Gastroenterol8:141-145, 1986
7.
Ippoliti AF, Sturdevant RL: Cimetidine versus intensive antacid therapy for peptic ulcer disease . Gastroenterology74:391-395, 1978
8.
Dal Negro R. : Famotidine and theophylline: A cimetidine like pharmacokinetic interaction . Ital J Chest Dis42:185-186, 1988
9.
Nagazawa S., Nagashima R., Samlof IM: Selective binding of sucralfate to gastric ulcer in man. Dig Dis Sci26:297-300, 1981
10.
Hollander D. : Efficacy of sucralfate for duodenal ulcers: A multicentered, doubleblind trial. J Clin Gastroenterol3:153-157, 1981 (suppl 2)
11.
Marks IN, Lucke W., Wright JP, et al: Ulcer healing and relapse rates after treatment with cimetidine or sucralfate. J Clin Gastroenterol3:163-165, 1981 (suppl 2)
12.
Brandstaetter G., Kratpchvil P.: Comparison of two sucralfate dosages (2 g twice a day versus lg four times daily) in duodenal ulcer healing. Am J Med79:36-38, 1985 (suppl 2C)
13.
Van Deventer GM, Schneidman D., Walsh JH: Sucralfate and cimetidine as single agents and in combination for treatment of active duodenal ulcers, a double-blind placebo control trial. Am J Med79:39-44, 1985 (suppl 2c)
14.
Freidman GD , Siegelaub AB, Seltzer CC: Cigarettes, alcohol, coffee and peptic ulcer . N Engl J Med290:469-473, 1974
15.
Scharschmidt BF: Peptic ulcer disease-Pathophysiology and current medical management [Medical Staff Conference]. West J Med146:724-733, 1987
16.
Shulman ES, McKenzie CA, Graham L.: How H2Antagonists have changed ulcer therapy. US Pharm7:53-70,1989
17.
Bettarello A.: Anti-ulcer therapy. Past to present. Dig Dis Sci30:36-42, 1985 (suppl 11)
18.
Simonsen LL : New prescription volume increases 4.2% moving total rxs up 1.4%. Pharm Times54:38-46, 1988
19.
Armstrong CP , Blower AL: Non-steroidal antiinflammatory drugs and life threatening complications of peptic ulceration. Gut28:527-532, 1987
20.
Carson JL, Strom BL, Soper KA, et al: The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med147:85-88, 1987
21.
Ivey KJ: Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage. Am J Med84:41-48, 1988 (suppl 2a)
22.
Graham DY: Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy. Gastroenterology96:675-681, 1989
Caruso I., Porro GB: Gastroscopic evaluation of antiinflammatory agents. Br Med J1:75-78, 1980
26.
Carson JL, Strom BL, Morse ML, et al: The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch Intern Med147:1054-1059,1987
27.
Aadland E., Fausa O., Vatn M., et al: Protection by misoprostol against naproxen-induced gastric mucosal damage. Am J Med83:37-40,1987 (suppl 1a)
28.
Lanza FL: A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects. Dig Dis Sci31:131-136, 1986 (suppl)
29.
Jiranek GC, Kimmey MB, Saunders DR, et al: Misoprostol reduces gastroduodenal injury from one week of aspirin: An endoscopic study. Gastroenterology96:656-661, 1989
30.
Lanza FL, Aspinall RL, Swabb EA, et al: Doubleblind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostal versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology95:294-298, 1988
31.
Graham DY, Agrawal NM, Roth SH: Prevention of NSAID-induced gastric ulcer with misoprostol: Multicentre, double-blind, placebo-controlled trial. Lancet2:1277-1280, 1988
32.
Wildeman RA : Focus on misoprostol: Review of worldwide safety data. Clin Invest Med10:243-245, 1987
33.
Anonymous: Misoprostol. Med Lett Drugs Ther31:21-22, 1989
34.
Semble EL, Wu WC: Antiinflammatory drugs and gastric mucosal damage. Semin Arthritis Rheum16:271-286, 1987
35.
American Hospital Formulary Service, Drug Information 1989 . Washington, DC, American Society of Hospital Pharmacists , 1989, p 1668
36.
O'Laughlin JC, Silvoso GR, Ivey KJ: Healing of aspirin-associated peptic ulcer disease despite continued salicylate ingestion. Arch Intern Med141:781-783, 1981
37.
Manniche C. , Malchow-Moller A., Andersen JR, et al: Randomized study of the influence of non-steroidal antiinflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease. Gut28:226-229, 1987
38.
Lucas CE, Sugawa C., Riddle J., et al: Natural history and surgical dilemma of "stress" gastric bleeding . Arch Surg102:266-273, 1971
39.
Skillman JJ , Bushnell LS, Goldman H., et al: Respiratory failure, hypotension, sepsis, and jaundice. Am J Surg117:523-530, 1969
40.
Schuster DP , Rowley H., Feinstein S., et al: Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med76:623-629, 1984
41.
Hastings PR , Skillman JJ, Bushnell LS, et al: Antacid titration in the prevention of acute gastrointestinal bleeding. N Engl J Med298:1041-1045,1978
42.
Priebe HJ, Skillman JJ, Bushnell LS, et al: Antacid versus cimetidine in preventing acute gastrointestinal bleeding. N Engl J Med302:426-430, 1980
43.
Czaja AJ, McAlhany JC, Pruitt BA: Acute gastroduodenal disease after thermal injury. N Engl J Med291:925-929, 1974
44.
Shuman RB, Shuster DP, Zuckerman GR: Prophylactic therapy for stress ulcer bleeding: A reappraisal. Ann Intern Med106:562-567, 1987
45.
Anderberg B. , Sjodahl R.: Prophylaxis and management of stress ulcers . Scand J Gastroenterol20:101-104, 1985 (suppl 110)
46.
Borrero E., Ciervo J., Chang JB: Antacid vs sucralfate in preventing acute gastrointestinal tract bleeding in abdominal aortic surgery. Arch Surg121:810-812, 1986
47.
Borrero E., Margolis IB, Bank S., et al: Antacid versus sucralfate in preventing acute gastrointestinal bleeding. Am J Surg148:809-812, 1984
48.
Borrero E., Bank S., Margolis I., et al: Comparison of antacid and sucralfate in the prevention of gastrointestinal bleeding in patients who are critically ill. Am J Med79:62-64, 1985 (suppl 2c)
49.
Stothert JC, Simonowitz DA, Dellinger EP, et al: Randomized prospective evaluation of cimetidine and antacid control of gastric pH in the critically ill. Ann Surg192:169-174, 1980
50.
Martin LF, Max MH, Polk HC: Failure of gastric pH control by antacids or cimetidine in the critically ill: A valid sign of sepsis. Surgery88:59-68, 1980
51.
Poleski MH, Spanier AH: Cimetidine versus antacids in the prevention of stress erosions in critically ill patients. Am J Gastroenterol81:107-111, 1986
52.
More DG, Raper RF, Munro IA, et al: Randomized, prospective trial of cimetidine and ranitidine for control of intragastric pH in the critically ill. Surgery97:215-223, 1985
53.
Reid SR, Bayliff CD: The comparative efficacy of cimetidine and ranitidine in controlling gastric pH in critically ill patients. Can Anaesth Soc J33:287-293, 1986
54.
Morris DL, Markham SJ, Beechey A., et al: Ranitidine-bolus or infusion prophylaxis for stress ulcer. Crit Care Med16:229-232, 1988
55.
McAlhany JC , Czaja AJ, Pruitt BA: Antacid control of complications from acute gastroduodenal disease after burns. J Trauma16:645-649, 1976
56.
Albin M., Friedlos J., Hillman K.: Continuous intragastric pH measurement in the critically ill and treatment with parenteral ranitidine. Int Care Med11:295-299, 1985
57.
Hauser A., Quigley ML, Driever CW, et al: More on false-positive "hemoccult" reaction with cimetidine . N Engl J Med304:847-848, 1981
58.
Layne EA, Mellow MH, Lipman TO: Insensitivity of guaiac slide tests for detection of blood in gastric juice . Ann Intern Med94:774-776, 1981
59.
Pinilla JC, Oleniuk FH, Reed D., et al: Does antacid prophylaxis prevent upper gastrointestinal bleeding in critically ill patients?Crit Care Med13:646-650, 1985
60.
Rosenthal P. , Thompson J., Singh M.: Detection of occult blood in gastric juice . J Clin Gastroenterol6:119-121, 1984
